Navigate to
-
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax....
-
Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
9 Comprehensive outcomes reporting Insert Link Learn more about cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Tab 1 Holistic...
-
Connect care for your members with cancer Home Our solutions Specialty drug management IntegratedRx IntegratedRx - Oncology Reducing the risk of major side effects IntegratedRx® streamlines the...